William N. Haddad
Partner
Bill Haddad is a corporate attorney who handles the full range of securities offerings and corporate transactions. Bill focuses on securities, public and private financings, mergers and acquisitions, and general corporate matters, including joint ventures, partnerships, and corporate formations. His clients include privately held and publicly traded companies, family offices, venture capital firms, investment banks, financial institutions, and private equity sponsors – especially in the United States, Asia, Europe, and Australia.
Bill has been involved in more than 100 capital markets transactions, drawing on his extensive familiarity and strength in the following areas:
- Initial and follow-on public offerings
- Special-purpose acquisition companies (SPACs)
- Shelf-takedowns
- Registered directs
- PIPEs
- At-the-market offerings
- Mergers of public and private companies
- Going-private transactions
- Private equity and venture capital formation and investments
- 144A debt offerings of public and private companies
- Rights offerings
Prior to practicing law, Bill worked for Moody's Investor Services and the United States Bankruptcy Court, and as a certified public accountant at Ernst and Young LLP.
Related Practices
Experience +
Experience
+
Representative Matters
- Represented ThinkEquity, as underwriter, in the $21 million public offering of Annovis Bio, Inc.
- Represented Translational Development Acquisition Corp., a special-purpose acquisition company, in its $172.5 million IPO
- Represented Allarity Therapeutics in the $1 million ATM offering
- Represented a special-purpose acquisition company in its merger with a provider of space-based data and analytics in a transaction valued at approximately $1.6 billion
- Represented a publicly traded electric vehicle and fintech company in acquisitions of a title insurance company, a wireless charging station manufacturer, a solar tractor company, and a manufacturer of power conversion systems
- Represented Counter Press Acquisition Corporation, a special-purpose acquisition company, in its $86.25 million IPO
- Represented Avalon Acquisition Inc., a special-purpose acquisition company, in its $207 million IPO
- Represented NavSight Holdings, Inc, a special-purpose acquisition company in its $230 million IPO
- Represented LF Capital Acquisition, a special-purpose acquisition company, in its $135 million IPO
- Represented an agriculture technology company in connection with Seed, Seed-II, and Series A financing rounds
- Represented the underwriter in the public offering of MAIA Biotechnology, Inc.
- Represented a global electric vehicle company that is focused on driving the adoption of electric commercial vehicles, in its public offer launch for the purchase of an electric vehicle company listed on the Italian stock exchange
- Represented the underwriters in the IPO of MAIA Biotechnology, Inc.
- Represented the underwriters in the IPO of Context Therapeutics Inc.
- Represented Avalon Acquisition, a special-purpose acquisition company, in connection with a business combination with Beneficient Company Group, a leading alternative liquidity provider, at an implied enterprise value of $3.5 billion
- Represented AJP Holding Company in a strategic equity financing of $17.5 million in Sonim Technologies, a manufacturer of durable mobile devices
- Represented Allarity Therapeutics, Inc. in connection with a private placement of senior convertible notes
- Represented ThinkEquity, as sales agent, in the ATM offering of MAIA Biotechnology, Inc.
- Represented the underwriters in the IPO of Azitra, Inc.
- Represented Avalon Acquisition, a special-purpose acquisition company, in connection with a business combination with Beneficient Company Group, L.P., a technology-enabled platform providing liquidity, data, custody, and trust services to holders of alternative assets at an enterprise value of $3.5 billion
- Represented Second Sight Medical Products, a leading developer of implantable visual prosthetics, in its reverse acquisition of Nano Precision Medical, a biopharmaceutical business that develops miniaturized, subdermal drug implants, at an implied enterprise value of $285 million
- Represented a global electric vehicle company, in an $88.5 million registered at-the-market offering
- Represented Zinc Nacional, S.A. in the acquisition of Steel Dust, a zinc dust steel recycler
- Represented a major online audiobook and podcast service in its sale to a multinational corporation
- Represented Cazador Acquisition, a special-purpose acquisition company, in its IPO
- Represented Cazador Acquisition, a special-purpose acquisition company, in its $350 million business combination with Net Element, a leading mobile commerce company
- Represented China Hydroelectric Corporation in its $50 million Note Purchase Agreement
- Represented China Hydroelectric Corporation in its $150 million Convertible Preferred Financing
- Represented China Hydroelectric Corporation in its $50 million Secured Exchange Note Financing
- Represented C Media in its $25 million Series B investment into You on Demand
- Represented ChinaGrowth North Acquisition Corporation, a special-purpose acquisition company, in its IPO
- Represented ChinaGrowth South Acquisition Corporation, a special-purpose acquisition company, in its IPO
- Represented ChinaGrowth North Acquisition Corporation, a special-purpose acquisition company, in its business combination
- Represented CONSOL Energy in a $400 million private placement of equity
- Represented CONSOL Energy in a $400 million Revolving Credit Facility
- Represented CONSOL Energy in a $250 million Note Exchange
- Represented Ripplewood in the acquisition of Micro Craft Inc.
- Represented Inter-Atlantic Financial, Inc., a special-purpose acquisition company, in its $69 million IPO
- Represented Robertson Stephens in a Series B financing for a tech company
- Represented the underwriters in the public offering of Venaxis
- Represented the underwriters in the public offering of Yulong Eco Materials Limited
- Represented APAX Partners & Co in its APAX Israel II $100 million fund
- Represented the placement agent in the convertible senior note financing for Cell Therapeutics
- Represented the underwriters in the public offering of Ascent Solar
- Represented the underwriters in the public offering of Vuzix
- Represented NetCreations in its sale to Seat Pagine Gialle
- Represented the underwriter in the $40 million public offering of 55.com
- Represented the placement agent in the Series A financing for Hospitality Systems, Inc.
Insights +
Insights
+
Thought Leadership
December 11, 2024
Fifth Circuit Vacates Nasdaq's Board Diversity Rules: Key Implications for the 2025 Proxy Season
Fifth Circuit Vacates Nasdaq's Board Diversity Rules: Key Implications for the 2025 Proxy SeasonDecember 15, 2023
Navigating SEC Cybersecurity Disclosure Guidance for Public Companies
Navigating SEC Cybersecurity Disclosure Guidance for Public CompaniesDecember 09, 2021
SEC Finalizes Rule That Affords PCAOB Oversight of Foreign Issuer Books and Raises the Specter of Delisting Non-Compliant Issuers
SEC Finalizes Rule That Affords PCAOB Oversight of Foreign Issuer Books and Raises the Specter of Delisting Non-Compliant IssuersEvents
January 13 - 16, 2025 San Francisco, CA
Venable at the J.P. Morgan Healthcare Conference and CSSi LifeSciences Annual Partnering Forum 2025
Venable at the J.P. Morgan Healthcare Conference and CSSi LifeSciences Annual Partnering Forum 2025January 08 - 11, 2024 San Francisco, CA
Venable at the J.P. Morgan Healthcare Conference and CSSi LifeSciences Annual Partnering Forum 2024
Venable at the J.P. Morgan Healthcare Conference and CSSi LifeSciences Annual Partnering Forum 2024June 02, 2021
SPAC: The Quick Alternative to IPO
SPAC: The Quick Alternative to IPORecent News
September 28, 2022
Venable Represents Avalon Acquisition in $3.5 Billion Merger with Beneficient Company Group
Venable Represents Avalon Acquisition in $3.5 Billion Merger with Beneficient Company GroupMarch 15, 2022
Venable LLP Represented Ideanomics Inc. in Its Public Offer Launch for the Purchase of Energica Motor Company S.p.a.
Venable LLP Represented Ideanomics Inc. in Its Public Offer Launch for the Purchase of Energica Motor Company S.p.a.December 28, 2021
Law360 Quotes Bill Haddad on Increased Regulatory Scrutiny of SPACs
Law360 Quotes Bill Haddad on Increased Regulatory Scrutiny of SPACsCredentials +
Credentials
+
Education
- J.D. Fordham University School of Law 1994
- B.S. University of Pennsylvania, Wharton School 1989
Bar Admissions
- New York
Professional Memberships and Activities
- Chair, Wharton Alumni Angel Network